Why PCOS Makes Semaglutide and Tirzepatide Work Differently — What Insulin Resistance and Elevated Androgens Do to Your GLP-1 Results

If you have PCOS and you’re pursuing PCOS weight loss with semaglutide or tirzepatide, you are not starting from the same place as someone without it. The biology is genuinely different. Insulin resistance runs deeper, androgens disrupt the hormonal environment that GLP-1 medications depend on, and the feedback loops that regulate appetite and metabolism are already under strain before the first injection. That matters for your results — and it matters even more for what happens when results slow down or stop. Understanding why helps you ask better questions and find a program that is built to answer them.

What PCOS Does to Metabolism Before Any Medication

Polycystic ovary syndrome is a hormonal and metabolic condition, not simply a reproductive one. At its core, most women with PCOS have one or more of three overlapping problems: elevated androgens (excess testosterone and DHEA-S), disrupted ovarian function driven by an abnormal LH-to-FSH ratio, and insulin resistance that is often more severe than a fasting glucose or A1c alone will reveal.

Insulin resistance in PCOS is not just about blood sugar. When cells resist insulin, the pancreas compensates by producing more of it. High circulating insulin then signals the ovaries to produce more testosterone and suppresses sex hormone-binding globulin (SHBG) — the protein that keeps testosterone from being biologically active. Lower SHBG means more free testosterone. More free testosterone worsens the androgen environment, disrupts ovulation, and contributes directly to fat storage around the abdomen and trunk. This loop feeds itself.

Elevated androgens also affect how fat cells behave. Women with PCOS tend to store fat in a pattern more similar to visceral adiposity, which is metabolically active and inflammatory. Inflammation worsens insulin signaling. Insulin resistance worsens androgen excess. The cycle compounds, and it does not pause simply because a GLP-1 medication is introduced.

How GLP-1 Medications Work — and Where PCOS Changes the Equation

GLP-1 receptor agonists like semaglutide and tirzepatide work through several mechanisms simultaneously. They slow gastric emptying, reduce appetite signals in the brain, improve insulin sensitivity, and — in the case of tirzepatide specifically — also act on GIP receptors, adding a second pathway for glucose regulation and fat metabolism.

These mechanisms are genuinely useful in PCOS. GLP-1 medications directly address insulin resistance, and there is growing evidence that they can reduce androgen levels and improve menstrual regularity in women with PCOS as insulin sensitivity improves. This is one reason a physician-supervised GLP-1 weight loss program can be a meaningful fit for women managing PCOS — when the program is designed to account for the additional complexity involved.

But PCOS also introduces variables that can blunt or complicate GLP-1 outcomes in ways a standard weight loss approach will not catch. Here is what matters most:

Insulin Resistance Severity Varies Widely

Two women with PCOS can have very different degrees of insulin resistance. A fasting glucose in the normal range does not rule it out. Fasting insulin, HOMA-IR (a calculated ratio of insulin to glucose), and sometimes a two-hour glucose tolerance test paint a more complete picture. A program that only checks A1c is not seeing the full problem — and cannot calibrate a medication plan around it.

Elevated Androgens Affect Metabolic Response

Free testosterone and DHEA-S levels directly influence how the body stores and releases fat. A woman with PCOS and significantly elevated free androgens is working against a hormonal current that GLP-1 medications alone do not fully redirect. Addressing androgen levels — through medication, SHBG optimization, or thyroid correction — is part of a complete plan, not an optional add-on.

Thyroid Function Is Frequently Overlooked

Research published in Frontiers in Endocrinology (2023) specifically examined the relationship between thyroid function and PCOS. Thyroid dysfunction is meaningfully more common in women with PCOS than in the general population, and subclinical hypothyroidism — where TSH is mildly elevated but still within the “normal” range on a standard lab panel — can significantly blunt weight loss response. TSH alone is an incomplete picture. Free T3 and Free T4 tell you whether the thyroid is actually delivering at the cellular level.

Progesterone Levels Are Unreliable to Test During Active Cycling in PCOS

Standard progesterone testing is not a useful guide to dosing decisions in pre- or perimenopausal women with PCOS because levels fluctuate significantly with cycle phase — and cycles in PCOS are often irregular or absent. Treating symptoms, not just lab numbers, is the clinical standard here. A program that relies on a single progesterone draw to make a hormone decision is likely to misread the picture.

The Labs a Real PCOS Weight Loss Program Should Run

Not every weight loss clinic checks the markers that matter for PCOS. A comprehensive initial panel for a pre- or perimenopausal woman with PCOS should include, at minimum:

• Complete metabolic panel and CBC — baseline organ function and inflammatory markers
• Fasting insulin and glucose — to calculate HOMA-IR and assess true insulin resistance severity
• Hemoglobin A1c — three-month glucose average
• Free and total testosterone — to quantify androgen excess
• DHEA-S — adrenal androgen contribution
• SHBG — reflects how much free androgen is biologically active
• Free T3, Free T4, and TSH — thyroid function beyond just TSH
• Lipid panel — PCOS carries elevated cardiovascular risk
• Vitamin D — deficiency worsens insulin resistance and is extremely common in this population

Follow-up labs should track how these markers shift as treatment progresses. If androgen levels are not improving alongside weight, or if thyroid function is suboptimal, that information belongs in the treatment plan — not just in a file.

What a GLP-1 Plateau in PCOS Often Means

When a woman with PCOS hits a plateau on semaglutide or tirzepatide — weight loss slows, stops, or reverses — the instinct in many clinics is to increase the dose. Sometimes that is appropriate. Often, there is something else going on that a dose increase will not fix.

When GLP-1 stops working or weight comes back, the answer is often in the blood work. Made Ya Skinny takes a functional medicine approach — running the right labs, reading them correctly, and building a plan around what your body actually needs rather than just increasing the dose. For a woman with PCOS, that means asking whether thyroid function has drifted, whether androgens have been adequately addressed, whether insulin resistance has truly improved or just been masked, and whether a nutrient deficiency like vitamin D or B12 is interfering with metabolic recovery. These are answerable questions. But only if someone is asking them.

What to Look for in a Medical Weight Loss Program if You Have PCOS

A program designed for women with PCOS should do more than prescribe a medication and check a scale. Here is what genuinely distinguishes a thorough approach:

• Comprehensive initial labs that include androgens, thyroid function, and insulin markers — not just A1c and a metabolic panel
• Physician oversight, not just a questionnaire and a pharmacy shipment
• Monitoring at regular intervals — especially in year one, when the body is responding and dose adjustments matter
• Willingness to address hormones directly when they are part of the problem — not just weight as a number, but the physiology behind it
• Honest communication about what the labs show, including markers that are inconvenient or that require a more complex answer than adding milligrams

No honest clinic can promise a specific number of pounds lost, a fixed timeline, or the same result for every patient. PCOS adds real complexity, and individual results vary. What a good program can promise is that your treatment plan reflects your actual biology — not a generic protocol.

Medical Weight Loss for PCOS in Magnolia and Cypress, TX

Made Ya Skinny serves women across Magnolia, Cypress, The Woodlands, Conroe, Willis, Montgomery, Tomball, and North Houston, with telehealth available across multiple states. The approach is physician-guided, lab-driven, and designed to address the full picture — not just the medication. If you have PCOS and you want a program that understands why your results might look different than someone else’s, that conversation starts with the right labs and a provider who knows how to read them.

Start with a visit to our physician-supervised GLP-1 weight loss program page to learn how we approach complex cases. When you’re ready to move forward, book your $17 visit to meet with our physician and get the labs ordered. Individual results vary — but a plan built around your actual biology is where results begin.

Frequently Asked Questions

Does semaglutide work for PCOS weight loss?

Semaglutide can be effective for women with PCOS because it directly targets insulin resistance, which is a core driver of PCOS-related weight gain. Some research also suggests it may help reduce androgen levels as insulin sensitivity improves. However, PCOS introduces additional factors — including elevated androgens, thyroid dysfunction, and deeper insulin resistance — that can affect results. A program that accounts for these variables through comprehensive labs and physician oversight is more likely to produce meaningful outcomes than one that does not. Individual results vary.

Why might GLP-1 medications stop working for someone with PCOS?

A GLP-1 plateau in a woman with PCOS often signals that something beyond dose is at play. Common contributors include suboptimal thyroid function (particularly low Free T3), persistently elevated androgens or low SHBG, vitamin D deficiency, and ongoing insulin resistance that has not adequately resolved. Running the right follow-up labs and reading them correctly — rather than simply increasing the medication dose — is the appropriate next step.

Is tirzepatide better than semaglutide for PCOS?

Tirzepatide activates both GLP-1 and GIP receptors, which gives it a second pathway for improving insulin sensitivity and glucose regulation. For women with PCOS whose insulin resistance is a dominant feature, this dual mechanism may offer additional benefit. Whether tirzepatide or semaglutide is the better fit for a specific patient depends on that individual’s labs, history, and how they respond — a decision made by a physician who has reviewed the full picture, not a general comparison.

What labs should be checked for PCOS before starting a weight loss program?

A comprehensive pre-treatment panel for PCOS should include free and total testosterone, DHEA-S, SHBG, fasting insulin and glucose (for HOMA-IR), A1c, Free T3, Free T4, TSH, a complete metabolic panel, CBC, lipid panel, and vitamin D. These markers capture the metabolic and hormonal landscape that determines how a woman with PCOS will respond to treatment — and what will need to be addressed alongside a GLP-1 medication.

Can hormones affect weight loss results in women with PCOS?

Yes. Elevated androgens, low progesterone (common in anovulatory PCOS), thyroid dysfunction, and persistently high insulin all directly affect how the body stores and releases fat. A weight loss program that only manages the medication and ignores these hormonal drivers is treating symptoms rather than causes. For women with PCOS, hormone evaluation and weight loss work best as a coordinated plan, not parallel tracks.